For years, large companies have competed to offer better and better employee benefits. Free gym memberships, private healthcare, wellbeing apps, flexible working, mental health support and enhanced insurance packages have all become part of the battle to attract and retain talented staff.
But a recent decision by PwC in the US shows that even the biggest firms eventually hit a financial limit.
The Big Four firm has decided it will no longer cover popular weight-loss drugs such as Ozempic and Mounjaro for employees unless they have diabetes. Staff using the drugs primarily for weight management will no longer receive coverage through the company’s healthcare scheme.
This might sound like a fairly niche healthcare story but in reality, it highlights a much bigger issue facing businesses around the world: what happens when employee wellbeing becomes extremely expensive?
The rise of weight-loss drugs
The rise of GLP-1 weight-loss drugs has been one of the biggest healthcare stories of recent years. Originally designed to help people manage type 2 diabetes, the drugs quickly gained global attention because many users experienced dramatic weight loss. Social media exploded with success stories, celebrities openly discussed using them, and demand surged almost overnight.
The problem is that these treatments are not cheap. In the UK, some of the strongest doses can cost more than £300 a month. In the United States, where healthcare costs are already notoriously high, the figures can become even more eye-watering once insurance coverage is involved.
That leaves employers with a difficult decision. If a company’s healthcare plan covers these drugs for thousands of employees, the costs can spiral very quickly. Research from Blue Cross Blue Shield suggested that including GLP-1 drugs in healthcare coverage could increase employer insurance premiums by as much as 14%. For a huge organisation employing tens of thousands of people, that could potentially mean millions in additional annual costs.
Suddenly, what started as a wellbeing benefit becomes a major financial issue.
Financial logic versus employee expectations
What makes this particularly interesting is the clash between financial logic and employee expectations. From PwC’s perspective, the decision appears to be about controlling rapidly rising healthcare costs and keeping benefits sustainable over the long term. From the perspective of some employees, however, the move feels unfair and lacking in empathy.
Some people may argue that employees in professional services spend extremely long hours sitting behind computer screens, often working under high levels of stress with little time for exercise. In that context, some may feel obesity and weight-related issues are not simply personal lifestyle choices but partly linked to modern working culture itself.
That creates an uncomfortable question for businesses: to what extent should employers be responsible for health problems connected to the way modern jobs operate?
There is no simple answer. Companies clearly want healthy employees. Healthier employees are often happier, more productive, and may take fewer sick days. But businesses also have budgets, shareholders, and financial targets to consider. At some point, management has to decide where the line is between supporting employee wellbeing and taking on costs that are difficult to sustain.
The danger of removing benefits
What makes this situation even more sensitive is that once employees become used to a benefit, they often start seeing it as part of their overall compensation package. Removing it later can create frustration, damage morale, and even affect recruitment and retention. A benefit that initially looked attractive and progressive can therefore become a long-term financial commitment that businesses struggle to reverse.
This is something many organisations may increasingly face in the future. Healthcare technology is advancing rapidly, with new treatments, personalised medicine, genetic therapies, and AI-driven health services becoming more common. Many of these innovations could improve lives significantly, but they may also come with very high price tags.
Businesses may therefore find themselves having more difficult conversations about what they can realistically afford to provide through employee healthcare schemes.
What business students can learn
For business students, this story is a very useful reminder that management decisions are rarely straightforward. It is easy to say companies should prioritise employee wellbeing, but real-world decisions usually involve balancing multiple competing pressures at the same time. Businesses have to think about costs, reputation, employee morale, competitiveness, recruitment, productivity, and long-term sustainability. Often all at once!
In many ways, the PwC story is really about strategic decision-making under pressure. The company is trying to balance financial realities with employee expectations in an area where emotions, health, and money are all deeply connected.
And as healthcare costs continue rising around the world, this almost certainly will not be the last time companies are forced to rethink the benefits they offer their employees.
